97761835 - ELXR

Information

• Trademark
• 97761835

• Source

• Serial Number

  97761835

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  January 20, 2023
  a year ago

• Transaction Date

  July 03, 2023
  a year ago

• Status Date

  July 02, 2023
  a year ago

• Location Date

  July 02, 2023
  a year ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  DIBLE, JONATHON I

• Attorney Docket Number

  333322.temp

  Attorney Name

  John Paul Oleksiuk

  Law Office Assigned Location Code

  M20

• Owners

  • Scribe Therapeutics, Inc.

Case File Statements

• GS0051: Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics in the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics in the nature of diseases caused by genetic mutations or for which gene modification would ameliorate or cure the disease or disorder; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders
• PM0001: ELIXIR

Case File Event Statements

• 7/3/2023 - a year ago

  9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 7/2/2023 - a year ago

  8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 7/2/2023 - a year ago

  7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 3/14/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/14/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/14/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/9/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/26/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/24/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP